Alexion Pharmaceuticals Inc (ALXN)

ALXN (NASDAQ:Drugs)
$188.05
pos +10.27
+5.78%
Today's Range: 172.35 - 189.03 | ALXN Avg Daily Volume: 1,107,800
Last Update: 01/29/15 - 4:00 PM EST
Volume: 3,011,812
YTD Performance: -3.92%
Open: $172.58
Previous Close: $177.78
52 Week Range: $129.80 - $203.30
Oustanding Shares: 198,286,879
Market Cap: 35,763,021,496
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 11
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.30 1.30 1.30 1.32
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 75.15
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
75.15 75.30 25.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.50% 33.66% 135.78%
GROWTH 12 Mo 3 Yr CAGR
Revenue 36.80 1.87 0.42
Net Income -0.80 1.61 0.37
EPS -1.40 1.35 0.32
Earnings for ALXN:
EBITDA 0.60B
Revenue 1.55B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.17 $1.29 $4.72 $5.54
Number of Analysts 4 1 4 4
High Estimate $1.24 $1.29 $4.79 $5.93
Low Estimate $1.13 $1.29 $4.67 $5.05
Prior Year $0.80 $1.41 $2.75 $4.72
Growth Rate (Year over Year) 45.94% -8.51% 71.55% 17.38%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Timothy Collins

 | Jan 8, 2015 | 10:09 AM EST
Do you need to pick one name?
By

Kate Stalter

 | Jan 6, 2015 | 12:00 PM EST

They are prone to being whipsawed by news.

bearishAlexion downgraded at Morgan Stanley

Jan 5, 2015 | 6:36 AM EST

ALXN was downgraded from Overweight to Equal-weight, Morgan Stanley said. $202 price target. Valuation call, as the company has limited near-term catalysts. 

By

Bob Byrne

 | Nov 13, 2014 | 7:30 AM EST

A few stocks that could break higher.

By

Carolyn Boroden

 | Nov 3, 2014 | 8:30 AM EST

As these examples illustrate, it's just good risk management.

By

Kate Stalter

 | Oct 30, 2014 | 2:00 PM EDT

Some growth leaders in the sector are getting technical support.

By

Scott Redler

 | Sep 4, 2014 | 5:25 PM EDT

Updating our current trade ideas.

By

Carolyn Boroden

 | Jun 15, 2014 | 11:00 AM EDT

The stock seems liable to reenter its uptrend, so here's how to play it.

By

Jim Cramer

 | Apr 14, 2014 | 11:49 AM EDT

Cautionary tales that the IPO window might be closing at last.

By

Scott Redler

 | Apr 3, 2014 | 6:43 PM EDT

Intel  breaks above our target on Piper Jaffray upgrade.

January 29, 2015, 4:34 P.M. ET "Where Did That Come From? Dow Jumps 225 Points, S&P 50...
There is a small bullish MacD divergence on the daily Energy Select Sector SPDR (XLE) char...
Remember IF that last low in LNKD is good, we should hold on a pullback to it....Note we a...
Auditor of REITs in American Realty Capital Resigned The Grant Thornton accounting firm re...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.